Skip to content

Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)

Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06410495
Enrollment
30
Registered
2024-05-13
Start date
2024-05-01
Completion date
2025-12-01
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Chronic, Oppositional Defiant Disorder

Brief summary

In this proposal a brief web-based cognitive behavioral treatment for insomnia (CBT-I) for children with oppositional defiant disorder (ODD) and their parents is iteratively adapted and tested for acceptability, feasibility, and preliminary efficacy.

Interventions

BEHAVIORALNiteCAPP SINCC

Standard CBT-I techniques along with modules targeting noncompliance in children with ODD and their parents.

Sponsors

University of South Florida
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Child ages 8-17 with ODD (prior diagnosis) and insomnia 2. Child and parent English proficiency. Insomnia: 1. complaints of difficulties falling asleep, staying asleep, or early morning awakening by child report or parent observation for 3+ mos 2. daytime dysfunction (mood, cognitive, social, academic) due to insomnia 3. baseline diaries and actigraphy indicate \>30 mins. of sleep onset latency, wake after sleep onset, or early morning awakening (time between last awakening and out of bed time) on 6+ nights

Exclusion criteria

1. Parent unable to provide informed consent or child unable to provide assent 2. Family unwilling to accept random assignment 3. Child/parent participation in another randomized research project 4. Parent unable to complete forms or implement treatment procedures due to cognitive impairment 5. Child untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias) 6. Child psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin 7. Child participation in non-pharmacological treatment (including CBT) for sleep outside current trial 8. Parent report of inability to undergo Holter Monitoring or actigraphy (e.g., extreme sensitivity, behavioral outbursts) 9. Other conditions adversely affecting trial participation

Design outcomes

Primary

MeasureTime frameDescription
Child Daily Sleep DiariesEach morning for 14-days at 0 weeks, 6 weeks, and 10 weeksDaily diaries filled out by children with parent assistance that measure sleep efficiency, sleep onset latency, and total sleep time. Diaries also measure child behavior.
Parent Daily Sleep DiariesEach morning for 14-days at 0 weeks, 6 weeks, and 10 weeksDaily diaries filled out by parent that measure sleep efficiency, sleep onset latency, and total sleep time. Diaries also measure child behavior.

Secondary

MeasureTime frameDescription
Child Heartrate Variabilityduring a cold-pressor task at 0 weeks, 6 weeks, 10 weeksChild heartrate variability will be measured during the following: 1) resting state, 2) cold pressor stimulation to hand (place hand to bottom of 4° Celsius ice water) for 30 secs, 3) 3 min recovery, 4) cold pressor stimulation to other hand for 30secs, 5) resting state
Parent Heartrate Variabilityduring a cold-pressor task at 0 weeks, 6 weeks, 10 weeksParent heartrate variability will be measured during the following: 1) resting state, 2) cold pressor stimulation to hand (place hand to bottom of 4° Celsius ice water) for 30 secs, 3) 3 min recovery, 4) cold pressor stimulation to other hand for 30secs, 5) resting state
The Revised Childhood Anxiety and Depression Scale0 weeks, 6 weeks, 10 weeksMeasures child anxiety and depression
PROMIS Child Sleep Disturbance0 weeks, 6 weeks, 10 weeksMeasures child sleep
Alabama Parenting Questionnaire0 weeks, 6 weeks, 10 weeksMeasures parenting behaviors
Perceived Stress Scale0 weeks, 6 weeks, 10 weeksMeasures parent stress
Child Actigraphy24/7 during the 2 week assessment at 0 weeks, 6 weeks, and 10 weeksPhysiological measure of sleep efficiency, sleep onset latency, and total sleep time
State-Trait Anxiety Inventory0 weeks, 6 weeks, 10 weeksMeasures parent anxiety
Child Disruptive Behavior Disorders Checklist0 weeks, 6 weeks, 10 weeksMeasures child disruptive behaviors
PROMIS Adult Sleep Disturbance0 weeks, 6 weeks, 10 weeksMeasures parent sleep
Pediatric Sleep Questionnaire0 weeks, 6 weeks, 10 weeksMeasures child sleep apnea risk
Epworth Sleepiness Scale0 weeks, 6 weeks, 10 weeksMeasures parent sleep apnea risk
Beck Depression Inventory-II0 weeks, 6 weeks, 10 weeksMeasures parent depression
Parent Actigraphy24/7 during the 2 week assessment at 0 weeks, 6 weeks, and 10 weeksPhysiological measure of sleep efficiency, sleep onset latency, and total sleep time

Countries

United States

Contacts

Primary ContactMelanie Stearns, PhD
mstearns@usf.edu8123828872

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026